Patrick Jewell, MD
Radiation Oncology · Hilo, HINPI 1760593099
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $422 and has fallen 60.0% since, to $169 in 2025. That places this record below the midpoint for radiation oncology clinicians in HI, where the typical reported total is $723.
Across 30 payments — averaging $22.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$138
- Incyte Corporation$73
- AbbVie$73
- Johnson & Johnson$66
- Novocure Inc.$51
- Coherus Oncology, Inc.$48
- plus $225 from 9 others
What the payments were for
- Food & beverage$674100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 7 | $138 |
| Incyte Corporation | 3 | $73 |
| AbbVie | 4 | $73 |
| Johnson & Johnson | 1 | $66 |
| Novocure Inc. | 3 | $51 |
| Coherus Oncology, Inc. | 2 | $48 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Blueprint Medicines Corporation | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Pfizer | 1 | $23 |
| EMD Serono, Inc. | 1 | $22 |
| Siemens Medical Solutions USA, Inc. | 1 | $22 |
| Mirati Therapeutics, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $20 |
How this compares
$674 in reported general payments places this provider in the 45th percentile of 27 radiation oncology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pilocarpine Hcl | 15 | $1,416 |
| Pentoxifylline | 18 | $1,397 |
| Tamsulosin Hcl | 58 | $1,293 |
| Mometasone Furoate | 35 | $953 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $569 |
| Dexamethasone | 25 | $359 |
| Ondansetron OdtOndansetron | 12 | $129 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Hilo
- Kevin WilcoxHilo$5K
- James LambethHilo$58
- Laeton PangHonolulu$10K
- Michael RoachHonolulu$9K
- Jared HaraHonolulu$3K
- Anthony MichaudHonolulu$3K
- John LedererHonolulu$3K
- Mark MayedaHonolulu$2K
- Christina SpeirsHonolulu$2K
- Samuel BirerHonolulu$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.